NAV / Share Forecast Mean Consensus

The following section summarizes insights on 's NAV / Share Forecast Mean Consensus:

• Milestone Scientific's latest twelve months ebitda minus 3yr avg capex margin is -78.0%
• Milestone Scientific's ebitda minus 3yr avg capex margin for fiscal years ending December 2020 to 2024 averaged -91.2%.
• Milestone Scientific's operated at median ebitda minus 3yr avg capex margin of -78.0% from fiscal years ending December 2020 to 2024.
• Looking back at the last 5 years, Milestone Scientific's ebitda minus 3yr avg capex margin peaked in December 2021 at -71.0%.
• Milestone Scientific's ebitda minus 3yr avg capex margin hit its 5-year low in December 2020 of -135.5%.
• Milestone Scientific's ebitda minus 3yr avg capex margin decreased in 2020 (-135.5%, +190.6%), 2022 (-99.7%, +40.3%), and 2024 (-78.0%, +8.6%) and increased in 2021 (-71.0%, -47.6%) and 2023 (-71.8%, -28.0%).